Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-07
DOI
10.1038/s41598-018-38311-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
- (2017) Kara N. Maxwell et al. Nature Communications
- Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance
- (2017) Rachel W Anantha et al. eLife
- Do platinum salts fit all triple negative breast cancers?
- (2016) L. Gerratana et al. CANCER TREATMENT REVIEWS
- BRCA1 -Mutated Estrogen Receptor–Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency
- (2016) Esther H. Lips et al. CLINICAL CANCER RESEARCH
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- Rapid Protein Depletion in Human Cells by Auxin-Inducible Degron Tagging with Short Homology Donors
- (2016) Toyoaki Natsume et al. Cell Reports
- Massively Parallel Functional Analysis of BRCA1 RING Domain Variants
- (2015) Lea M. Starita et al. GENETICS
- BRCA1 Mutation: A Predictive Marker for Radiation Therapy?
- (2015) Charlene Kan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The same, only different - DNA damage checkpoints and their reversal throughout the cell cycle
- (2015) I. A. Shaltiel et al. JOURNAL OF CELL SCIENCE
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Nuclear domain ‘knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing
- (2015) Jordan Pinder et al. NUCLEIC ACIDS RESEARCH
- Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
- (2015) Rohit Prakash et al. Cold Spring Harbor Perspectives in Biology
- Patterns and functional implications of rare germline variants across 12 cancer types
- (2015) Charles Lu et al. Nature Communications
- Massively Parallel Functional Analysis of BRCA1 RING Domain Variants
- (2015) Lea M. Starita et al. GENETICS
- Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks
- (2014) François Aymard et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Integrated analysis of germline and somatic variants in ovarian cancer
- (2014) Krishna L. Kanchi et al. Nature Communications
- Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype
- (2014) Sarah L. Sawyer et al. Cancer Discovery
- The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
- (2013) Shahneen K Sandhu et al. LANCET ONCOLOGY
- The BRCA1/BARD1-Interacting Protein OLA1 Functions in Centrosome Regulation
- (2013) Ayako Matsuzawa et al. MOLECULAR CELL
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants
- (2013) P. Bouwman et al. Cancer Discovery
- Analysis of BRCA1 Variants in Double-Strand Break Repair by Homologous Recombination and Single-Strand Annealing
- (2012) William I. Towler et al. HUMAN MUTATION
- Evolutionary Pathways in BRCA1-Associated Breast Tumors
- (2012) Filipe C. Martins et al. Cancer Discovery
- BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
- (2011) Rinske Drost et al. CANCER CELL
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
- (2011) Thomas Helleday Molecular Oncology
- BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity
- (2011) R. Shakya et al. SCIENCE
- Identification of Breast Tumor Mutations in BRCA1 That Abolish Its Function in Homologous DNA Recombination
- (2010) D. J.R. Ransburgh et al. CANCER RESEARCH
- Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
- (2010) Yvette Drew et al. JNCI-Journal of the National Cancer Institute
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Analysis of DNA Double-strand Break (DSB) Repair in Mammalian Cells
- (2010) Andrei Seluanov et al. Jove-Journal of Visualized Experiments
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
- (2008) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance
- (2008) E. M. Swisher et al. CANCER RESEARCH
- E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks
- (2008) L. J. Reid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now